Abstract
Angiotensin II receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors have comparable efficacy, but ARBs have a preferential safe......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
